Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease
Clinical trial NCT06221059 · COMPLETED
Trial details
- NCT number
- NCT06221059
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-02
- Primary completion
- 2025-03-05
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.